Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach by Chang-Gon Kim, Yun-Beom Sang, Ji-Hyun Lee, Hong-Jae Chon

Get full text

Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab by Yun Beom Sang, Chaeryoung Lee, Seul-Gi Kim, Boyoung Lee, Beodeul Kang, Chan Kim, Hong Jae Chon

Get full text

The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges by Yun Beom Sang, Joo-Hang Kim, Chang-Gon Kim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho, Sun Min Lim

Get full text

High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma by Yun Beom Sang, Hannah Yang, Won Suk Lee, Seung Joon Lee, Seul-Gi Kim, Jaekyung Cheon, Beodeul Kang, Chang Woo Kim, Hong Jae Chon, Chan Kim

Get full text

Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma by Young Shin Song, Hannah Yang, Beodeul Kang, Jaekyung Cheon, Ilhwan Kim, Hyeyeong Kim, Won Suk Lee, Yun Beom Sang, Sanghoon Jung, Ho Yeong Lim, Vincent E. Gaillard, Chan Kim, Hong Jae Chon

Get full text

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis by Jaekyung Cheon, Choong-kun Lee, Yun Beom Sang, Hye Jin Choi, Min Hwan Kim, Jun Ho Ji, Kwang Hyun Ko, Chang-Il Kwon, Dae Jung Kim, Sung Hoon Choi, Chan Kim, Beodeul Kang, Hong Jae Chon

Get full text